CoolSculpting(R) Procedure Achieves Strong Podium Presence at ASLMS 2014
April 03 2014 - 8:00AM
Marketwired
CoolSculpting(R) Procedure Achieves Strong Podium Presence at ASLMS
2014
PLEASANTON, CA--(Marketwired - Apr 3, 2014) - ZELTIQ®
Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company
focused on developing and commercializing products utilizing its
proprietary controlled-cooling technology platform, today announced
its CoolSculpting procedure, a non-surgical, clinically proven
procedure designed to selectively reduce fat in treated areas using
a patented cooling technology, will be featured in 10 podium
presentations and 7 e-posters at the American Society for Laser
Medicine and Surgery annual conference (ASLMS) in Phoenix, Ariz.,
April 2-6, 2014. Physicians will be presenting their own
data.
At the booth, the company will highlight the CoolSmooth™
applicator, the newest addition to the applicator platform for the
CoolSculpting procedure, featuring non-vacuum based cooling that
easily treats non-pinchable fat bulges and a comfortable design
that adjusts to fit each individual patient.
For the complete ASLMS program, visit www.aslms.org. For
information about the CoolSculpting procedure and CoolSmooth
applicator, visit ZELTIQ at Booth #515.
WHAT: CoolSculpting Procedure, CoolSmooth Applicator
ZELTIQ Booth #515
WHEN: ASLMS Exhibit Hours Friday, April 4, 2014, 9:00 a.m. -
5:00 p.m. Saturday, April 5, 2014, 9:00 a.m. - 7:00 p.m.
WHERE: American Society for Laser Medicine and Surgery (ASLMS)
Annual Conference Phoenix Convention Center 100 N 3rd Street
Phoenix, AZ 85004
About ZELTIQ® Aesthetics, Inc. ZELTIQ Aesthetics, Inc. is a
medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first
commercial product, the CoolSculpting system, is designed to
selectively reduce stubborn fat that may not respond to diet or
exercise. The CoolSculpting procedure is based on the
scientific principle that fat cells are more sensitive to cold than
the overlying skin and surrounding tissues. It utilizes
patented technology of precisely controlled cooling to reduce the
temperature of fat cells in the treated area, which is intended to
cause fat cell elimination through a natural biological process
known as apoptosis. ZELTIQ developed the CoolSculpting
procedure to safely, noticeably, and measurably reduce the fat
layer.
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024